Afib Ablation and Mental Health, Sedentary Behavior and Dementia, Ulcerative Colitis Review, and more
Editor’s Summary by Christopher W. Seymour, MD, MSc, Associate Editor of JAMA, the Journal of the American Medical Association, for the September 12, 2023, issue. Related Content: Audio Highlights (Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - September 12, 2023 Category: General Medicine Authors: JAMA Network Source Type: podcasts
Intrapartum Azithromycin and Neonatal and Maternal Outcomes, Olamkicept for Ulcerative Colitis, FDA Mandate Limiting Acetaminophen in Combination Opioid Products and Liver Failure, and more
Editor’s Summary by Kirsten Bibbins-Domingo, PhD, MD, MAS, Editor in Chief of JAMA, The Journal of the American Medical Association, for the March 7, 2023, issue. (Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - March 7, 2023 Category: General Medicine Authors: JAMA Network Source Type: podcasts
Initial safety trial results find increased risk of serious heart-related problems and cancer with arthritis and ulcerative colitis medicine Xeljanz, Xeljanz XR (tofacitinib)
Listen to FDA Drug Safety Podcast on Drug Safety Communication titled "Initial safety trial results find increased risk of serious heart-related problems and cancer with tofacitinib (Xeljanz, Xeljanz XR) (Source: FDA Drug Safety Podcasts)
Source: FDA Drug Safety Podcasts - February 8, 2021 Category: Drugs & Pharmacology Authors: U.S. Food and Drug Administration, Center for Drug Evaluation and Research U.S. Food and Drug Administration, Center for Drug Evaluation and Research Source Type: podcasts
FDA approves Boxed Warning about increased risk of blood clots and death with higher dose of arthritis and ulcerative colitis medicine tofacitinib (Xeljanz, Xeljanz XR)
Listen to an audio podcast of the July 26, 2019 FDA Drug Safety Communication on FDA approval of Boxed Warning about increased risk of blood clots and death with higher dose of arthritis and ulcerative colitis medicine tofacitinib (Xeljanz, Xeljanz XR). (Source: FDA Drug Safety Podcasts)
Source: FDA Drug Safety Podcasts - December 21, 2019 Category: Drugs & Pharmacology Authors: U.S. Food and Drug Administration, Center for Drug Evaluation and Research Source Type: podcasts
Effect of FMT on Ulcerative Colitis, HSCT for MS, Review of Penicillin Allergy, and more
Editor's Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the January 15, 2019 issue (Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - January 15, 2019 Category: General Medicine Authors: JAMA Network Source Type: podcasts
PodMed – Week of May 8, 2017
This week’s topics include lowering cholesterol and outcomes, a new agent for ulcerative colitis, handgun purchases after mass shooting events, and bystander CPR and long term outcomes. Program notes: 0:31 Handgun purchases after mass shootings 1:31 Tripled over time period 2:31 Constraints on gun research 2:45 Bystander CPR and use of defibrillators 3:45 More likely […] (Source: Johns Hopkins Medicine Weekly Health News)
Source: Johns Hopkins Medicine Weekly Health News - May 5, 2017 Category: Consumer Health News Authors: Elizabeth Tracey Tags: Digestive Disorders Heart And Vascular PodMed Safety Source Type: podcasts
TWiV 323: A skid loader full of viromes
Hosts: Vincent Racaniello, Dickson Despommier, Alan Dove, and Kathy Spindler
The family TWiVidae discuss changes in the human fecal virome associated with Crohn's disease and ulcerative colitis.
Links for this episode
Enteric virome changes in inflammatory bowel disease (Cell)
Gov. Christie stumbles on vaccination (NY Times)
Anti-vax psychology (NPR)
Vaccine skeptic changes her mind (NPR)
Ebolavirus sitrep (WHO)
Letters read on TWiV 323
Weekly Science Picks
Alan - SitesuckerRich - Snake picked wrong dinnerDickson ...
Source: This Week in Virology - MP3 Edition - February 7, 2015 Category: Virology Authors: Vincent Racaniello Source Type: podcasts
Mesalamine Dosage and Fecal Calprotectin in Patients With Quiescent Ulcerative Colitis
A study in the November issue of CGH investigated whether increasing doses of mesalamine reduces concentrations of fecal calprotectin in patients with quiescent ulcerative colitis. Dr. Kuemmerle speaks to author Dr. James D. Lewis. (Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - November 26, 2014 Category: Gastroenterology Authors: AGA Source Type: podcasts
William J. Sandborn, MD - Practical Considerations in the Management of Patients With Ulcerative Colitis
Practical Considerations in the Management of Patients With Ulcerative Colitis (Source: PeerView Press CME/CE International Audio Podcast - Internal Medicine)
Source: PeerView Press CME/CE International Audio Podcast - Internal Medicine - September 15, 2014 Category: Internal Medicine Authors: Answers in CME Tags: Science, Medicine Source Type: podcasts
William J. Sandborn, MD - The Expanding Role of Biologic Therapies for Ulcerative Colitis: Assessing the State of the Science and Implications for Practice
(Source: PeerView Press CME/CE International Audio Podcast - Internal Medicine)
Source: PeerView Press CME/CE International Audio Podcast - Internal Medicine - August 29, 2014 Category: Internal Medicine Authors: Answers in CME Tags: Science, Medicine Source Type: podcasts
